41
Per their March 22, 2016 News Release: Lexaria absorption and flavor enhancing technology provides improved food consumption experiences and performance. Increasingly, companies realize that flavour enhancement and more efficient and effective absorption of active molecules not only benefits consumers, but is becoming a necessity as companies look to individualize their products and compete in increasingly crowded market sectors. Lexaria’s technology provides significant competitive advantages to its licensed partners. To date, there are companies in both the Cannabis and the Hemp industries benefiting from Lexaria’s technology –and in Canada as well as the USA. In October 2016, the U.S. Patent and Trademark Office (“USPTO”) issued U.S. Patent No. 9,474,725, Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof, pertaining to Lexaria’s method of improving bioavailability and taste of certain cannabinoid lipophilic active agents in food products. Lexaria has several other patents pending in Canada, the USA, and in 41 other countries.
In February 2017, Lexaria signed a Master Collaborative Research Agreement with the National Research Council of Canada (NRC) “to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient composition”. This 18 month study with an equal shared cost to not exceed CAD$250,000 ($125,000 per partner). According to the news release, “the collaboration will investigate and define the chemical nature of the molecular association that Lexaria`s patented technology is believed to effectuate between lipophilic active agents and fatty acids as solubility and bioavailability enhancing agents. Effective delivery of lipophilic active agents' spans across industry sectors such as, food, vitamins, pharmacy and more, which are multi-billion dollar opportunities”.
Neutrisci International, Inc. (Neutriscri) highlights
NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci has focused on the development of several breakthrough nutraceutical products with an initial focus on areas such as heart and cholesterol health, sleep deprivation therapies, immune defense as well as men’s prostate and sexual health. NeutriSci continues to build strong relationships and distribution channels for its BluScience™ and NeuEnergy™ products with retailers throughout the United States. NeutriSci is focusing efforts in strengthening sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers. www.neutrisci.com
According to their website: “NeutriSci International Inc. is a leader in the innovation, production and formulation of clinically-proven nutraceuticals containing pterostilbene, the active stilbenoid most commonly found in blueberries. Our Company’s primary focus is our product, neuenergy. Neuenergy represents a new concept for providing energy and focus without the high levels of caffeine, taurine and sugar usually found in today’s energy drinks and shots.
This development has allowed the Company to gain traction and market share in a
growing $27 billion dollar per year industry”.
Their neuenergy is a chewable tablet that is gluten free, sugar free, and with zero calories and carbs. Their formulation allows for sublingual absorption which is far more efficient and effective than GI absorption. The multi-billion dollar energy drink market has recently found itself under increased scrutiny including health concerns. Per the neuenergy product data, each tablet has about half the caffeine of a small brewed cup of coffee and contains the same amount of pterostilbene as found in 25,000 fresh blueberries - neuenergy was issued U.S. Patent No. 8,399,712.